Physical activity as part of therapy of spondyloarthropathy - review
DOI:
https://doi.org/10.12775/QS.2025.39.58397Keywords
spondyloarthropathy, physical activity, exercise therapy, rheumatological diseasesAbstract
Spondyloarthropathy is a group of chronic inflammatory diseases involving the sacroiliac joints and spine. Due to the prevalence of spinal pain, its diagnosis is often delayed for up to several years. If left untreated, it leads to a significant deterioration of the patient's quality of life, disability, and eventually premature death. At present, there are drugs with which the disease activity can be effectively controlled, although some of them are not widely used due to their high cost. Despite the development of modern technology and the increasing spectrum of available therapies, rehabilitation and exercise still remain one of the basic elements of treatment. This article discusses and evaluates various forms of physical activity in terms of their effects on disease activity, joint and non-joint complaints, inflammatory markers and patient well-being. The most important conclusion of the analysis is that physical activity is safe for patients and it is never too late to start.
References
1 - Ingram T, Sengupta R, Standage M, Barnett R, Rouse P. Correlates of physical activity in adults with spondyloarthritis and rheumatoid arthritis: a systematic review. Rheumatol Int. 2022;42(10):1693-1713. doi:10.1007/s00296-022-05142-z
2 - Hay CA, Packham J, Ryan S, Mallen CD, Chatzixenitidis A, Prior JA. Diagnostic delay in axial spondyloarthritis: a systematic review. Clin Rheumatol. 2022;41(7):1939-1950. doi:10.1007/s10067-022-06100-7
3 - Deodhar A, Blanco R, Dokoupilová E, Hall S, Kameda H, Kivitz AJ, Poddubnyy D, van de Sande M, Wiksten AS, Porter BO, Richards HB, Haemmerle S, Braun J. Improvement of Signs and Symptoms of Nonradiographic Axial Spondyloarthritis in Patients Treated With Secukinumab: Primary Results of a Randomized, Placebo-Controlled Phase III Study. Arthritis Rheumatol. 2021;73(1):110-120. doi:10.1002/art.41477
4 - Stolwijk C, van Onna M, Boonen A, van Tubergen A. Global Prevalence of Spondyloarthritis: A Systematic Review and Meta-Regression Analysis. Arthritis Care Res (Hoboken). 2016;68(9):1320-1331. doi:10.1002/acr.22831
5 - Liu J, Dong Z, Zhu Q, He D, Ma Y, Du A, He F, Zhao D, Xu X, Zhang H, Jin L, Wang J. TNF-α Promoter Polymorphisms Predict the Response to Etanercept More Powerfully than that to Infliximab/Adalimumab in Spondyloarthritis. Sci Rep. 2016;6:32202. Published 2016 Aug 31. doi:10.1038/srep32202
6 - Dougados M, Wei JC, Landewé R, et al. Efficacy and safety of ixekizumab through 52 weeks in two phase 3, randomised, controlled clinical trials in patients with active radiographic axial spondyloarthritis (COAST-V and COAST-W) [published correction appears in Ann Rheum Dis. 2020 Jun;79(6):e75. doi: 10.1136/annrheumdis-2019-216118corr1]. Ann Rheum Dis. 2020;79(2):176-185. doi:10.1136/annrheumdis-2019-216118
7 - Karmacharya P, Duarte-Garcia A, Dubreuil M, Murad MH, Shahukhal R, Shrestha P, Myasoedova E, Crowson CS, Wright K, Davis JM. Effect of Therapy on Radiographic Progression in Axial Spondyloarthritis: A Systematic Review and Meta-Analysis. Arthritis Rheumatol. 2020;72(5):733-749. doi:10.1002/art.41206
8 - Wendling D, Hecquet S, Fogel O, Letarouilly JG, Verhoeven F, Pham T, Prati C, Molto A, Goupille P, Dernis E, Saraux A, Ruyssen-Witrand A, Lukas C, Miceli-Richard C, Hudry C, Richette P, Breban M, Gossec L, Dougados M, Claudepierre P. 2022 French Society for Rheumatology (SFR) recommendations on the everyday management of patients with spondyloarthritis, including psoriatic arthritis [published correction appears in Joint Bone Spine. 2022 Oct;89(5):105428. doi: 10.1016/j.jbspin.2022.105428]. Joint Bone Spine. 2022;89(3):105344. doi:10.1016/j.jbspin.2022.105344
9 - van der Linden S, Akkoc N, Brown MA, Robinson PC, Khan MA. The ASAS Criteria for Axial Spondyloarthritis: Strengths, Weaknesses, and Proposals for a Way Forward. Curr Rheumatol Rep. 2015;17(9):62. doi:10.1007/s11926-015-0535-y
10 - Kroon FP, van der Burg LR, Ramiro S, Landewé RB, Buchbinder R, Falzon L, van der Heijde D. Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis). Cochrane Database Syst Rev. 2015;2015(7):CD010952. Published 2015 Jul 17. doi:10.1002/14651858.CD010952.pub2
11 - Yi E, Ahuja A, Rajput T, George AT, Park Y. Clinical, Economic, and Humanistic Burden Associated With Delayed Diagnosis of Axial Spondyloarthritis: A Systematic Review. Rheumatol Ther. 2020;7(1):65-87. doi:10.1007/s40744-020-00194-8
12 - Proft F, Torgutalp M, Muche B, Rios Rodriguez V, Listing J, Protopopov M, Rademacher J, Haibel H, Spiller L, Weber AK, Verba M, Brandt-Juergens J, Kiltz U, Sieburg M, Jacki S, Sieper J, Poddubnyy D. Comparison of the effect of treatment with NSAIDs added to anti-TNF therapy versus anti-TNF therapy alone on the progression of structural damage in the spine over 2 years in patients with radiographic axial spondyloarthritis from the randomised-controlled CONSUL trial. Ann Rheum Dis. 2024;83(5):599-607. Published 2024 Apr 11. doi:10.1136/ard-2023-224699
13 - Corbett M, Soares M, Jhuti G, Rice S, Spackman E, Sideris E, Moe-Byrne T, Fox D, Marzo-Ortega H, Kay L, Woolacott N, Palmer S. Tumour necrosis factor-α inhibitors for ankylosing spondylitis and non-radiographic axial spondyloarthritis: a systematic review and economic evaluation. Health Technol Assess. 2016;20(9):1-vi. doi:10.3310/hta20090
14 - Michielsens CAJ, Boers N, den Broeder N, Wenink MH, van der Maas A, Mahler EAM, Mulder MLM, van der Heijde D, van den Hoogen FHJ, Verhoef LM, den Broeder AA. Dose reduction and withdrawal strategy for TNF-inhibitors in psoriatic arthritis and axial spondyloarthritis: design of a pragmatic open-label, randomised, non-inferiority trial. Trials. 2020;21(1):90. Published 2020 Jan 15. doi:10.1186/s13063-019-4000-5
15 - Webers C, Ortolan A, Sepriano A, Falzon L, Baraliakos X, Landewé RBM, Ramiro S, van der Heijde D, Nikiphorou E. Efficacy and safety of biological DMARDs: a systematic literature review informing the 2022 update of the ASAS-EULAR recommendations for the management of axial spondyloarthritis. Ann Rheum Dis. 2023;82(1):130-141. doi:10.1136/ard-2022-223298
16 - Shim J, Dean LE, Karabayas M, Jones GT, Macfarlane GJ, Basu N. Quantifying and predicting the effect of anti-TNF therapy on axSpA-related fatigue: results from the BSRBR-AS registry and meta-analysis. Rheumatology (Oxford). 2020;59(11):3408-3414. doi:10.1093/rheumatology/keaa132
17 - Michielsens CAJ, Boers N, den Broeder N, Wenink MH, van der Maas A, Mahler EAM, Mulder MLM, van der Heijde D, van den Hoogen FHJ, Verhoef LM, den Broeder AA. Dose reduction and withdrawal strategy for TNF-inhibitors in psoriatic arthritis and axial spondyloarthritis: design of a pragmatic open-label, randomised, non-inferiority trial. Trials. 2020;21(1):90. Published 2020 Jan 15. doi:10.1186/s13063-019-4000-5
18 - Leverment S, Clarke E, Wadeley A, Sengupta R. Prevalence and factors associated with disturbed sleep in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a systematic review. Rheumatol Int. 2017;37(2):257-271. doi:10.1007/s00296-016-3589-x
19 - Hu L, Man S, Ji X, Wang Y, Liu X, Zhang J, Song C, Zhu J, Huang F. Risk of infections of biological and targeted drugs in patients with spondyloarthritis: meta-analysis of randomized clinical trials. Chin Med J (Engl). 2022;135(8):911-919. Published 2022 Apr 20. doi:10.1097/CM9.0000000000001928
20 - Man S, Hu L, Ji X, Wang Y, Ma Y, Wang L, Zhu J, Huang F. Risk of Malignancy and Tuberculosis of Biological and Targeted Drug in Patients With Spondyloarthritis: Systematic Review and Meta-analysis of Randomized Controlled Trials. Front Pharmacol. 2021;12:705669. Published 2021 Oct 29. doi:10.3389/fphar.2021.705669
21 - Deodhar A, van der Heijde D, Gensler LS, Kim TH, Maksymowych WP, Østergaard M, Poddubnyy D, Marzo-Ortega H, Bessette L, Tomita T, Leung A, Hojnik M, Gallo G, Li X, Adams D, Carlier H, Sieper J. Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial. Lancet. 2020;395(10217):53-64. doi:10.1016/S0140-6736(19)32971-X
22 - Deodhar A, Machado PM, Mørup M, Taieb V, Willems D, Orme M, Pritchett D, Gensler LS. Comparative efficacy and safety of bimekizumab in axial spondyloarthritis: a systematic literature review and network meta-analysis. Rheumatology (Oxford). 2024;63(5):1195-1205. doi:10.1093/rheumatology/kead598
23 - Braun J, Blanco R, Marzo-Ortega H, Gensler LS, van den Bosch F, Hall S, Kameda H, Poddubnyy D, van de Sande M, Wiksten AS, Porter BO, Shete A, Richards HB, Haemmerle S, Deodhar A. Secukinumab in non-radiographic axial spondyloarthritis: subgroup analysis based on key baseline characteristics from a randomized phase III study, PREVENT. Arthritis Res Ther. 2021;23(1):231. Published 2021 Sep 4. doi:10.1186/s13075-021-02613-9
24 - Mysler E, Burmester GR, Saffore CD, Liu J, Wegrzyn L, Yang C, Betts KA, Wang Y, Irvine AD, Panaccione R. Safety of Upadacitinib in Immune-Mediated Inflammatory Diseases: Systematic Literature Review of Indirect and Direct Treatment Comparisons of Randomized Controlled Trials. Adv Ther. 2024;41(2):567-597. doi:10.1007/s12325-023-02732-6
25 - Russell MD, Stovin C, Alveyn E, Adeyemi O, Chan CKD, Patel V, Adas MA, Atzeni F, Ng KKH, Rutherford AI, Norton S, Cope AP, Galloway JB. JAK inhibitors and the risk of malignancy: a meta-analysis across disease indications. Ann Rheum Dis. 2023;82(8):1059-1067. doi:10.1136/ard-2023-224049
26 - Venerito V, Del Vescovo S, Lopalco G, Proft F. Beyond the horizon: Innovations and future directions in axial-spondyloarthritis. Arch Rheumatol. 2023;38(4):491-511. Published 2023 Nov 22. doi:10.46497/ArchRheumatol.2023.10580
27 - Ramiro S, Nikiphorou E, Sepriano A, Ortolan A, Webers C, Baraliakos X, Landewé RBM, Van den Bosch FE, Boteva B, Bremander A, Carron P, Ciurea A, van Gaalen FA, Géher P, Gensler L, Hermann J, de Hooge M, Husakova M, Kiltz U, López-Medina C, Machado PM, Marzo-Ortega H, Molto A, Navarro-Compán V, Nissen MJ, Pimentel-Santos FM, Poddubnyy D, Proft F, Rudwaleit M, Telkman M, Zhao SS, Ziade N, van der Heijde D. ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update. Ann Rheum Dis. 2023;82:19–34. doi: 10.1136/ard-2022-223296.
28 - Perrotta FM, Lories R, Lubrano E. To move or not to move: the paradoxical effect of physical exercise in axial spondyloarthritis. RMD Open. 2021;7(1):e001480. doi:10.1136/rmdopen-2020-001480
29 - Gwinnutt JM, Wieczorek M, Balanescu A, Bischoff-Ferrari HA, Boonen A, Cavalli G, de Souza S, de Thurah A, Dorner TE, Moe RH, Putrik P, Rodríguez-Carrio J, Silva-Fernández L, Stamm T, Walker-Bone K, Welling J, Zlatković-Švenda MI, Guillemin F, Verstappen SMM. 2021 EULAR recommendations regarding lifestyle behaviours and work participation to prevent progression of rheumatic and musculoskeletal diseases. Ann Rheum Dis. 2023;82(1):48-56. doi:10.1136/annrheumdis-2021-222020
30 - Gensler LS. Physical activity in axial spondyloarthritis-tails from bench to bedside. Clin Rheumatol. 2016;35(6):1443-1445. doi:10.1007/s10067-016-3264-3
31 - van Wissen MAT, Teuwen MMH, van den Ende CHM, Vliet Vlieland TPM, den Broeder AA, van den Hout WB, Peter WF, van Schaardenburg D, van Tubergen AM, Gademan MGJ, van Weely SFE. Effectiveness and cost-effectiveness of longstanding exercise therapy versus usual care in patients with axial spondyloarthritis or rheumatoid arthritis and severe limitations: The protocols of two parallel randomized controlled trials. Physiother Res Int. 2022;27(1):e1933. doi:10.1002/pri.1933
32 - van Wissen MAT, van den Ende CHM, Gademan MGJ, Teuwen MMH, Peter WF, Mahler EAM, van Schaardenburg D, van Gaalen FA, Spoorenberg A, van den Hout WB, van Tubergen AM, Vliet Vlieland TPM, van Weely SFE. One-year effectiveness of long-term exercise therapy in people with axial spondyloarthritis and severe functional limitations. Rheumatology (Oxford). Published online June 8, 2024. doi:10.1093/rheumatology/keae323
33 - Sveaas SH, Bilberg A, Berg IJ, Provan SA, Rollefstad S, Semb AG, Hagen KB, Johansen MW, Pedersen E, Dagfinrud H. High intensity exercise for 3 months reduces disease activity in axial spondyloarthritis (axSpA): a multicentre randomised trial of 100 patients. Br J Sports Med. 2020;54(5):292-297. doi:10.1136/bjsports-2018-099943
34 - Sveaas SH, Dagfinrud H, Berg IJ, Provan SA, Johansen MW, Pedersen E, Bilberg A. High-Intensity Exercise Improves Fatigue, Sleep, and Mood in Patients With Axial Spondyloarthritis: Secondary Analysis of a Randomized Controlled Trial. Phys Ther. 2020;100(8):1323-1332. doi:10.1093/ptj/pzaa086
35 - Sveaas SH, Berg IJ, Fongen C, Provan SA, Dagfinrud H. High-intensity cardiorespiratory and strength exercises reduced emotional distress and fatigue in patients with axial spondyloarthritis: a randomized controlled pilot study. Scand J Rheumatol. 2018;47(2):117-121. doi:10.1080/03009742.2017.1347276
36 - Sveaas SH, Berg IJ, Provan SA, Semb AG, Hagen KB, Vøllestad N, Fongen C, Olsen IC, Michelsen A, Ueland T, Aukrust P, Kvien TK, Dagfinrud H. Efficacy of high intensity exercise on disease activity and cardiovascular risk in active axial spondyloarthritis: a randomized controlled pilot study. PLoS One. 2014;9(9):e108688. Published 2014 Sep 30. doi:10.1371/journal.pone.0108688
37 - Fernández García R, Sánchez Sánchez Lde C, López Rodríguez Mdel M, Sánchez Granados G. Effects of an exercise and relaxation aquatic program in patients with spondyloarthritis: A randomized trial. Med Clin (Barc). 2015;145(9):380-384. doi:10.1016/j.medcli.2014.10.015
38 - Oz HE, Duran G, Bayraktar D, Kara M, Solmaz D, Akar S. Effect of cervical stabilization exercises on cervical position error in patients with axial spondyloarthritis: a randomized controlled pilot study. Wirkung von Übungen zur Halsstabilisierung auf zervikale Positionsfehler der Halswirbelsäule bei Patienten mit axialer Spondyloarthritis: randomisierte kontrollierte Pilotstudie. Z Rheumatol. 2024;83(Suppl 1):48-54. doi:10.1007/s00393-022-01295-1
39 - Verhoeven F, Guillot X, Prati C, Mougin F, Tordi N, Demougeot C, Wendling D. Aerobic exercise for axial spondyloarthritis - its effects on disease activity and function as compared to standard physiotherapy: A systematic review and meta-analysis. Int J Rheum Dis. 2019;22(2):234-241. doi:10.1111/1756-185X.13385
40 - Bilberg A, Dagfinrud H, Sveaas SH. Supervised Intensive Exercise for Strengthening Exercise Health Beliefs in Patients With Axial Spondyloarthritis: A Multicenter Randomized Controlled Trial [published correction appears in Arthritis Care Res (Hoboken). 2022 Dec;74(12):2118. doi: 10.1002/acr.25066]. Arthritis Care Res (Hoboken). 2022;74(7):1196-1204. doi:10.1002/acr.24556
41 - Sveaas SH, Dagfinrud H, Johansen MW, Pedersen E, Wold OM, Bilberg A. Longterm Effect on Leisure Time Physical Activity Level in Individuals with Axial Spondyloarthritis: Secondary Analysis of a Randomized Controlled Trial. J Rheumatol. 2020;47(8):1189-1197. doi:10.3899/jrheum.190317
42 - Soulard J, Carlin T, Knitza J, Vuillerme N. Wearables for Measuring the Physical Activity and Sedentary Behavior of Patients With Axial Spondyloarthritis: Systematic Review. JMIR Mhealth Uhealth. 2022;10(8):e34734. Published 2022 Aug 22. doi:10.2196/34734
43 - Pina Gonçalves N, Emília Santos M, Silvério-António M, Donato H, Pimentel-Santos FM, Cruz E. The effects of physical exercise on axial spondyloarthritis - a systematic review. The effects of physical exercise on axial spondyloarthritis – a systematic review. ARP Rheumatol. Published online August 27, 2023.
44 - O'Dwyer T, O'Shea F, Wilson F. Exercise therapy for spondyloarthritis: a systematic review. Rheumatol Int. 2014;34(7):887-902. doi:10.1007/s00296-014-2965-7
45 - Teuwen MMH, Vlieland TPMV, van Weely SFE, Schoones JW, Rausch Osthoff AK, Juhl CB, Niedermann K, Gademan MGJ, van den Ende CHM. Quality of reporting and nature of harms in clinical trials on supervised exercise in patients with rheumatoid arthritis or axial spondyloarthritis. Rheumatol Int. 2024;44(1):25-39. doi:10.1007/s00296-023-05502-3
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Karolina Mikołajczak, Hanna Ćwirko, Urszula Garlak

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 83
Number of citations: 0